Companies / Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

Nasdaq: ORKACIK 907654MENLO PARK, CA

Financials · FY2023

Revenue$0
Net income$-105.43M
Total debt—
Cash$268.47M
Diluted EPS$-3.87
Shares outstanding66.2M

Ownership

66.2M shares outstanding · as of Jul 31, 2026
1.7%Insiders
Ownership
Insiders1.67%1,108,203
10%+ / strategic8.06%5,336,993
Institutions74.40%49,257,853
Public float15.87%10,506,650

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Klein Lawrence OttoCEOChief Executive Officer · Director
1.40%927,309
Sandler Laura LeeFormerChief Operating Officer
0.36%236,984
Dambkowski CarlDirector
0.18%116,483
Goncalves JoanaChief Medical Officer
0.05%33,377
Quinlan Paul TGeneral Counsel
0.05%31,034
Agarwal ArjunFormerSenior Vice President, Finance
0.03%18,863
Ball Kristine MDirector
——

Institutional holders 160

View all →
HolderValue% of shares
BlackRock, Inc.$474.92M7.54%
State Street Corporation$254.38M4.04%
Fmr LLC$220.09M10.97%
Remedium Capital Partners, LLC$149.00M2.36%
Viking Global Investors LP$130.80M4.03%
VR Adviser, LLC$125.74M6.27%
Fairmount Funds Management LLC$112.31M5.60%
Vanguard Group Inc$74.37M3.71%
Perceptive Advisors LLC$68.45M2.11%
Deep Track Capital, LP$65.52M3.26%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 2, 2026Sandler Laura Lee
Executive
SellCommon Stock$246.4K-9K
-4.01%
209,336
0.32% of shares
medium
Feb 17, 2026Goncalves Joana
Executive
SellCommon Stock$195.9K-6K
-14.78%
34,954
0.05% of shares
medium
Jan 15, 2026Goncalves Joana
Executive
SellCommon Stock$138.3K-4K
-51.43%
4,137
<0.01% of shares
medium
Mar 16, 2026Goncalves Joana
Executive
SellCommon Stock$119.6K-3K
-7.62%
35,195
0.05% of shares
medium
Mar 16, 2026Goncalves Joana
Executive
SellCommon Stock$117.2K-3K
-7.12%
38,097
0.06% of shares
medium
Jan 2, 2026Sandler Laura Lee
Executive
SellCommon Stock$91.4K-3K
-1.50%
206,192
0.31% of shares
low
Mar 2, 2026Sandler Laura Lee
Executive
SellCommon Stock$90.4K-3K
-1.11%
237,584
0.36% of shares
low
Jan 15, 2026Goncalves Joana
Executive
SellCommon Stock$84.4K-3K
-63.31%
1,518
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Group IncPassive13G—2,453,530—
RTW Investments, LPPassive13G/A———
Deep Track Capital, LPPassive13G/A—2,161,510—
BlackRock, Inc.Passive13G—3,175,483—
Viking Global Investors LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ORKA——687604108—